Skip to content

The effect of 650-nm semiconductor laser in the treatment and control of adolescent myopia and myopic amblyopia

The effect of 650-nm semiconductor laser in the treatment and control of adolescent myopia and myopic amblyopia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032172
Enrollment
Unknown
Registered
2020-04-22
Start date
2019-10-22
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention and control of myopia

Interventions

Myopia test group:30 patients were treated with the low-intensity laser for one month with a total of 3 times after basic examination, each time at an interval of 1 month, and followed up 6 months lat
Myopia test control group:30 patients were not treated after basic examination, no training, no intervention, followed up 6 months later.
myopic amblyopia test group:30 patients were treated with the low-intensity laser for one month with a total of 3 times after basic examination, each time at an interval of 1 month, and followed up 6
Myopia amblyopia test control group:30 patients were not treated after basic examination, no training, no intervention, followed up 6 months later.

Sponsors

Shenzhen Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children and adolescents aged 5–17 years who were diagnosed with myopia and myopic amblyopia.

Exclusion criteria

Exclusion criteria: 1. Children who are using atropine or orthokeratology for myopia control; 2. Secondary myopia, such as secondary myopia caused by retinopathy of prematurity or other eye diseases in infancy, or myopia complicated with some systemic syndromes, such as Marfan syndrome; 3. Those who have undergone intraocular surgery or have suffered ocular trauma such as penetrating injuries, severe chemical injuries, thermal burns, etc. 4. Those who have undergone myopia correction (such as LASIK); 5. Those whose refractive medium is opaque.

Design outcomes

Primary

MeasureTime frame
diopter progress of the subjects (D);

Secondary

MeasureTime frame
axial elongation of the subjects (mm);

Countries

China

Contacts

Public ContactHengwei Deng

Shenzhen Eye Hospital

dhw110@126.com+86 13510093392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026